ArticleJournal of current glaucoma practice
Intraocular Pressure and Medication Outcomes of a Novel Primary Trimming Technique for XEN Gel Stent.
Article in Journal of current glaucoma practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim and background: The XEN Gel Implant is a microstent, which aims to lower intraocular pressure by forming a subconjunctival bleb to drain aqueous. The aim of this study is to assess the IOP-lowering effects of a novel trimming surgical technique, which shortens the length of the XEN Gel Stent. Materials and methods: Patients who underwent placement of an XEN Gel Stent using the novel primary trimming technique from 10/2020 to 6/2023 were included for chart review. The technique includes an intentional trimming of the XEN about 1 mm prior to Results: Thirty cases were included. The average age of patients was 73.3 ± 11.7 years. The average preoperative IOP was 19.9 ± 5.8 mm Hg. The average number of preoperative glaucoma drops was 2.6 ± 1.2. The average IOP at postoperative month 1 (14.0 ± 5.7 mm Hg), postoperative month 6 (13.8 ± 7.6 mm Hg), and postoperative year 1 (13.3 ± 8.0 mm Hg) were all significantly lower than preoperative IOP ( Conclusion: This surgical trimming technique for the XEN Gel Stent showed significant reductions in IOP at postoperative month 1, month 6, and year 1, as well as the need for fewer postoperative glaucoma drops for adequate control. Clinical significance: This novel technique effectively lowers IOP among patients with a low IOP goal while maintaining a safety profile comparable to standard methods. How to cite this article: Atta S, Li A. Intraocular Pressure and Medication Outcomes of a Novel Primary Trimming Technique for XEN Gel Stent. J Curr Glaucoma Pract 2025;19(3):125-128.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.